Chimeric antigen receptor T-cell treatment for non-Hodgkin lymphoma: A comprehensive bone marrow evaluation with FDG PET/CT

Bimash Shrestha; Shashi Singh; Miraziz Ismoilov; Saira Niazi; Malia Ahmed; Niloofaralsadat Motamedi; Thomas  Werner; Mona-Elisabeth R. Revheim; Poul Høilund-Carlsen; Abass Alavi; William Raynor

Chimeric antigen receptor T-cell treatment for non-Hodgkin lymphoma: A comprehensive bone marrow evaluation with FDG PET/CT

Bimash Shrestha
, Shashi Singh
, Miraziz Ismoilov
, Saira Niazi
, Malia Ahmed
, Niloofaralsadat Motamedi
, Thomas Werner
, Mona-Elisabeth R. Revheim
, Poul Høilund-Carlsen
, Abass Alavi
, William Raynor

Hospital of the University of Pennsylvania
University of Pennsylvania
Oslo University Hospital
University of Oslo
Rutgers Robert Wood Johnson Medical School

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	The Journal of Nuclear Medicine
Vol/bind	64
Udgave nummer	Suppl. 1
Sider (fra-til)	1342
Antal sider	1
ISSN	0161-5505
Status	Udgivet - 2023
Begivenhed	SNMMI 2023 Annual Meeting - McCormick Place, Chicago, USA Varighed: 24. jun. 2023 → 27. jun. 2023

Konference

Konference	SNMMI 2023 Annual Meeting
Lokation	McCormick Place
Land/Område	USA
By	Chicago
Periode	24/06/2023 → 27/06/2023

Dokumenter og links

https://jnm.snmjournals.org/content/64/supplement_1/P1342

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Shrestha, B., Singh, S., Ismoilov, M., Niazi, S., Ahmed, M., Motamedi, N., Werner, T., Revheim, M.-E. R., Høilund-Carlsen, P., Alavi, A., & Raynor, W. (2023). Chimeric antigen receptor T-cell treatment for non-Hodgkin lymphoma: A comprehensive bone marrow evaluation with FDG PET/CT. The Journal of Nuclear Medicine, 64(Suppl. 1), 1342. https://jnm.snmjournals.org/content/64/supplement_1/P1342

@article{1e9563591bb5473c82e5390cd5f8f296,

title = "Chimeric antigen receptor T-cell treatment for non-Hodgkin lymphoma: A comprehensive bone marrow evaluation with FDG PET/CT",

author = "Bimash Shrestha and Shashi Singh and Miraziz Ismoilov and Saira Niazi and Malia Ahmed and Niloofaralsadat Motamedi and Thomas Werner and Revheim, \{Mona-Elisabeth R.\} and Poul H{\o}ilund-Carlsen and Abass Alavi and William Raynor",

year = "2023",

language = "English",

volume = "64",

pages = "1342",

journal = "The Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Hellenic Society of Nuclear Medicine",

number = "Suppl. 1",

note = "SNMMI 2023 Annual Meeting ; Conference date: 24-06-2023 Through 27-06-2023",

}

Shrestha, B, Singh, S, Ismoilov, M, Niazi, S, Ahmed, M, Motamedi, N, Werner, T, Revheim, M-ER, Høilund-Carlsen, P, Alavi, A & Raynor, W 2023, 'Chimeric antigen receptor T-cell treatment for non-Hodgkin lymphoma: A comprehensive bone marrow evaluation with FDG PET/CT', The Journal of Nuclear Medicine, bind 64, nr. Suppl. 1, s. 1342. <https://jnm.snmjournals.org/content/64/supplement_1/P1342>

TY - ABST

T1 - Chimeric antigen receptor T-cell treatment for non-Hodgkin lymphoma: A comprehensive bone marrow evaluation with FDG PET/CT

AU - Shrestha, Bimash

AU - Singh, Shashi

AU - Ismoilov, Miraziz

AU - Niazi, Saira

AU - Ahmed, Malia

AU - Motamedi, Niloofaralsadat

AU - Werner, Thomas

AU - Revheim, Mona-Elisabeth R.

AU - Høilund-Carlsen, Poul

AU - Alavi, Abass

AU - Raynor, William

PY - 2023

Y1 - 2023

M3 - Conference abstract in journal

SN - 0161-5505

VL - 64

SP - 1342

JO - The Journal of Nuclear Medicine

JF - The Journal of Nuclear Medicine

IS - Suppl. 1

T2 - SNMMI 2023 Annual Meeting

Y2 - 24 June 2023 through 27 June 2023

ER -